Gland Pharma

quarterly
yearly
ParticularsMar '25Jun '25Sep '25Dec '25Mar '26
Revenue1,4691,5631,5711,7591,854
Expenses1,1811,2501,2871,3721,348
EBITDA391.54425.29398.05498.05624.49
Operating Profit295.78324.24291.74366.06515.83
Profit Before Tax288.33312.74283.91362.13505.80
Net Profit186.54215.48183.68261.48366.68
Financial Ratios
Operating Profit Margin27.48%28.25%26.77%27.94%35.83%
Net Profit Margin13.09%14.31%12.35%16.43%21.04%
Earning Per Share (Diluted)11.3213.0811.1515.8722.23
Dividends Per Share0.000.000.000.000.00